Products 2025: Positive Airway Pressure & Sleep Therapy
RT takes a look at positive airway pressure interfaces, masks, and sleep therapy devices from Cadwell, Mercury Medical, and Philips.
RT takes a look at positive airway pressure interfaces, masks, and sleep therapy devices from Cadwell, Mercury Medical, and Philips.
RT takes a look at positive airway pressure interfaces, masks, and sleep therapy devices from Cadwell, Mercury Medical, and Philips.
Read MoreStrong family relationships and high parental engagement are among the aspects of social connectedness that are associated with sufficient sleep duration in pre-teen children.
Read MorePoor sleep quality is related to relationship insecurity, which moderates the effect of sleep quality on daily feelings of jealousy, according to a new study presented at Sleep 2025.
Read MoreSleep medicine professionals favor CPAP therapy to treat comorbid obesity and obstructive sleep apnea, while patients lean toward treatment with weight loss medication tirzepatide (Zepbound).
Read MoreOral microbiome diversity is positively associated with long sleep duration among teenagers and young adults, according to a new study to be presented at Sleep 2025.
Read MoreAntidepressants that suppress REM sleep are associated with improved survival in people with amyotrophic lateral sclerosis (ALS), according to research at ATS 2025.
Read MoreUnder the most likely climate change scenarios, the societal burden of obstructive sleep apnea is expected to double in most countries over the next 75 years.
Read MoreA wearable pulse oximeter and connected software platform from Apnimed show promise for monitoring obstructive sleep apnea (OSA) and other sleep-related breathing diseases.
Read MoreResmed’s NightOwl is a disposable home sleep test that uses a fingertip sensor to record up to 10 nights of sleep data and transmitting it to clinicians via the user’s smartphone.
Read MoreExcessive screen time in adolescents disrupts sleep, increasing the risk of depression—especially among girls.
Read MoreAdenotonsillectomy was tied to a 32% reduction in medical visits and a 48% reduction in prescription use among children with mild sleep-disordered breathing.
Read MoreA study published in Neurology found that women in their 80s who experienced increasing daytime sleepiness over five years had double the risk of developing dementia.
Read MoreA worldwide study of over one million patients with sleep apnea provides the strongest evidence to date that CPAP therapy not only alleviates OSA symptoms but can also prolong life.
Read MoreAs the annual “spring forward” to observe daylight saving time approaches on March 9, new Gallup polling data reveals a majority of Americans want to eliminate the practice.
Read MoreResults from ResMed’s fifth annual Global Sleep Study reveal the toll that poor sleep takes on health, work, and relationships.
Read MoreDiabetic patients with severe obstructive sleep apnea showed a 58% increase in all-cause mortality.
Read MoreA study demonstrates comparable performance between the wireless, patch-based sleep test system and in-lab polysomnography for sleep staging and respiratory event detection.
Read MoreThe trial will evaluate the drug’s potential to reduce upper airway obstruction and nocturnal hypertension in patients with moderate-to-severe OSA.
Read MoreOptical imaging combines with computational fluid dynamics to provide precise 3D reconstructions of the upper airway, improving the detection and localization of obstructive sleep apnea.
Read MoreThe AASM issued a statement in response to the FDA’s approval of Zepbound for OSA patients with obesity, highlighting its potential as a new treatment option while cautioning about its limitations and the importance of sustained weight loss.
Read MoreA new AI technique using fully homomorphic encryption achieved 99.56% accuracy in detecting sleep apnea while safeguarding patient data.
Read MoreThe FDA has approved Zepbound as the first prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity.
Read MoreSleep apnea may lead to increased brain growth in the hippocampus, which could have implications for memory and cognitive function.
Read MoreThe EMA has determined that Mounjaro’s existing weight management approval includes its benefits for treating obstructive sleep apnea, eliminating the need for a separate application for an OSA indication.
Read More